ALAB vs MET · P/E 78, rev $852.5M vs P/E 13, rev $38.23B
Astera Labs, Inc. Common Stock (ALAB) versus MetLife Inc (MET) — a side-by-side from cached financials, not a winner call.
Astera Labs, Inc. Common Stock (ALAB) is a semiconductors company listed on US.
MetLife Inc (MET) is a insurance - life company listed on US.
Latest reported ALAB revenue for 2025-12-31 was $852.5M. Net income was $219.1M. Revenue was up 115.1% from 2024-12-31 to 2025-12-31. ALAB currently screens at market cap $16.84B and trailing P/E 78.0.
Latest reported MET revenue for 2026-06-30 was $38.23B. Net income was $1.92B. MET currently screens at market cap $52.16B and trailing P/E 12.7.
ALAB currently screens at market cap $16.84B and trailing P/E 78.0. MET currently screens at market cap $52.16B and trailing P/E 12.7.
Not investment advice. Open the ALAB and MET stock pages for the full models.
Not investment advice.